Illumina spending more than $1 billion to acquire Pacific Biosciences, increase its IP portfolio

November 05, 2018 | News Commentary

Illumina is making another significant step to consolidate its ownership of the next-generation sequencing (NGS) space. Its flagship short-read NGS technology is already the dominant approach for most applications across food,...